Immune Oncology Research Institute

This study tests a drug called balstilimab in 20 adults with certain lymphomas (classical Hodgkin lymphoma or primary mediastinal B-cell lymphoma) that have returned or not responded to standard treatments. Participants receive the drug every 3 weeks to see if it shrinks tumors a…

This study creates a worldwide registry for people diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), a very rare blood cancer. Researchers will collect information on how the disease presents, how it is treated, and what happens to patients over time. The goal …

This international registry will gather data from 500 people diagnosed with cardiac angiosarcoma, a rare and aggressive heart cancer. Researchers aim to identify risk factors and evaluate which treatments—like surgery, chemo, or immunotherapy—work best. The goal is to create evid…